According to research conducted at the Faculty of Human Sciences at Metropolitan University in London, cannabidiol can increase the effectiveness of conventional antibiotics treatment.
In order for bacteria to communicate with human cells, they release membrane vesicles. Scientists have recently discovered that the antibacterial effect of CBD is partly due to how cannabidiol acts on these membrane vesicles.
Inhibition of bacterial membrane vesicles
CBD has been found to be a potent inhibitor of this process in Gram-negative bacteria E. coli, whereas in Gram-positive Staphylococcus aureus its activity was negligible.
CBD sensitizes Gram-negative bacteria E. coli VCS257 to selected antibiotics.
Reducing antibiotic resistance
The researchers concluded that “CBD may pose as a putative adjuvant agent for tailored co-application with selected antibiotics, depending on bacterial species, to increase antibiotic activity, including via membrane vesicle inhibition, and help reduce antibiotic resistance.”
CBD helps reduce bacterial resistance to antibiotics.
The study was published in Frontiers in Cellular and Infection Microbiology 2019, 9:324.
Source: Magazín Konopí
